Search for: "United States v. Articles of Drug" Results 261 - 280 of 2,460
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Sep 2022, 5:23 am by Eugene Volokh
[Jack Goldsmith and I will have this article out in the Texas Law Review early next year, and I'm serializing it here. [read post]
2 Sep 2022, 3:31 pm by Kalvis Golde
United States 22-118Issues: (1) Whether the jury clauses of Article III and the Sixth Amendment or the due process clause of the Fifth Amendment bar a court from imposing a more severe criminal sentence on the basis of conduct that a jury necessarily rejected, given its verdicts of acquittal on other counts at the same trial; (2) whether the Supreme Court‘s decision in United States v. [read post]
31 Aug 2022, 10:21 pm by Bennett Cyphers
It claims to process over 250 million devices per month within the United States. [read post]
31 Aug 2022, 6:43 am by Ezra Rosser
The return of judicial discretion with the United Supreme Court’s decision in United States v. [read post]
  The Executive Order endorsed this approach, noting that “this order reaffirms that the United States retains the authority to challenge transactions whose previous consummation was in violation of the [antitrust laws]. [read post]
27 Aug 2022, 11:02 am by Camilla Hrdy
In the course of this work I encountered Section 1905 in the following way.There was, and still is, a federal law on the books enacted in 2007 called the Food and Drug Administration Amendments Act that mandates that important information from the majority of significant clinical trials run in the United States be published on the National Institute of Health (NIH) website. [read post]
25 Aug 2022, 9:03 pm by Bryn Hines
The guidance, issued in the aftermath of the Dobbs v. [read post]
19 Aug 2022, 9:30 pm by ernst
Jackson Lecturer on the Supreme Court of the United States at the Chautauqua Institution. [read post]
12 Aug 2022, 4:24 am by Ashley Morgan
The LCD states the following: “Evaluation of the clinical literature indicates that studies comparing the efficacy of CTPs to alternative wound care approaches with patients’ autologous skin are limited in number, apply mainly to generally healthy patients, and examine only a small portion of the CTP products available in the United States. [read post]
11 Aug 2022, 10:07 am by Jo Dale Carothers
The Federal Circuit recently addressed this issue in Thaler v. [read post]